Every major medical advance creates two kinds of questions. The first is scientific: Can we do it? The second is societal: How should we do it, who should be responsible, and under what safeguards?
Pakistan has spent decades developing its capacity to answer the first question. The next challenge is becoming equally serious about the second.
That makes the Health and Education Summit Pakistan (HESP 2026), being held at Expo Centre Lahore on 29-30 August, more than another gathering of institutions, professionals and policymakers. Its real opportunity lies in bringing together disciplines that increasingly depend on one another but too often continue to operate in isolation. Among them, medicine and law need a much closer conversation.
Healthcare is changing rapidly. Artificial intelligence is entering diagnosis and clinical decision-making; digital platforms are changing how patients reach doctors and hospitals; medical records are becoming large pools of sensitive data; genetics is opening possibilities that were unimaginable a generation ago; and assisted reproductive technologies have already transformed traditional understandings of conception, parenthood and family formation. These developments should not be feared. Innovation is essential to better healthcare. But innovation without an accompanying governance framework creates uncertainty precisely where confidence is most needed.
A doctor may determine whether a medical intervention is clinically appropriate, while an engineer may establish whether an artificial-intelligence system performs accurately. Yet neither question alone tells us who bears responsibility if an AI-supported decision contributes to patient harm. Technical efficiency does not determine how much information a patient should receive before consenting to an unfamiliar technology, and the ability to collect health data does not answer who should have access to it, how long it should be retained, or whether it may be reused for research or commercial purposes. These are fundamental questions of law, ethics and governance.
Pakistan therefore needs to think seriously about building a proactive medico-legal ecosystem.
The term should not be understood narrowly. Medico-legal work is often associated with negligence claims, forensic evidence, litigation or disputes arising after something has already gone wrong. Those functions remain important, but an equally important, and often overlooked, role of law is exercised before a dispute occurs. Good governance is preventive before it becomes punitive.
Health-law scholars, bioethicists and socio-legal researchers should increasingly be part of conversations about hospital governance, patient rights, clinical ethics, health-data protection, digital medicine and emerging biomedical technologies. Their role should not begin when a complaint reaches a courtroom; it should begin when policies, systems and technologies are being designed.
Artificial intelligence makes this need particularly clear. AI-supported tools may help doctors analyse images, predict risks, organise hospital resources and identify patterns that would otherwise take far longer to detect. These possibilities deserve serious investment, but responsible adoption also requires clear answers concerning human oversight, explainability, bias, professional responsibility and patient disclosure.
If an algorithm assists a doctor, does responsibility remain entirely with the clinician? What level of human supervision should be mandatory? Should a patient know that AI contributed to a diagnosis? How should an institution respond when an algorithm performs differently across populations? Those are not reasons to halt innovation; they are reasons to govern it well.
The same principle applies to health data. A paper medical record once remained largely inside a hospital or clinic. Today, information moves among hospitals, laboratories, mobile applications, researchers, insurers and technology providers. The traditional idea of medical confidentiality must therefore evolve into a broader framework of data stewardship, one that protects privacy while allowing legitimate research and innovation.
Reproductive medicine provides another clear lesson. Pakistan has its own history of engaging early with new reproductive technologies. Prof. Dr Rashid Latif Khan introduced IVF technology in Pakistan in 1984, and Pakistan’s first IVF baby followed in 1989. That history illustrates something larger than a medical milestone: once technology changes what is medically possible, law and society inevitably confront questions that did not previously exist in the same form.
Assisted reproduction raises questions of consent, parentage, embryo preservation, privacy, inheritance and family relationships. Genetics creates further questions about screening, intervention and the limits of parental or professional choice. Scientific expertise is indispensable to answering these challenges, but science cannot answer them alone.
Nor should Pakistan simply import regulatory models developed elsewhere. International experience is valuable, particularly as jurisdictions worldwide grapple with AI, digital health, genetics and reproductive medicine. But effective governance must also reflect Pakistan’s constitutional principles, ethical commitments, socio-economic structures, healthcare realities and its Shariah-informed normative environment. Context should not become an excuse for regulatory delay, but neither should modernisation be confused with copying.
This is where HESP 2026 can make a particularly meaningful contribution. The summit brings health professionals, educational institutions, policymakers, regulators, industry, researchers, technology specialists, international partners and diaspora expertise onto one platform. The next step is to ensure that legal, bioethical and socio-legal perspectives are integrated into that conversation as part of the innovation process itself.
Such integration need not mean creating another layer of bureaucracy. It could mean ensuring multidisciplinary representation in hospital ethics and technology committees; involving health-law and bioethics specialists when digital-health policies are drafted; creating focused research groups linking medical schools, law faculties, hospitals and regulators; and establishing a continuing policy forum through which emerging healthcare challenges are examined before they become public controversies.
Universities have a particularly important role to play. Their responsibility extends beyond producing graduates and publishing research papers. Universities can function as knowledge partners to hospitals, regulators and government by translating research into workable policy options.
For institutions where medicine, healthcare-technology and legal education already coexist, the opportunity is even greater. These environments can become laboratories for interdisciplinary governance, places where clinicians, legal scholars, ethicists, technologists and social scientists examine new problems together rather than from separate institutional silos.
The proposed Lahore Health & Education Declaration can provide a useful starting point if it recognises this need for continuity and interdisciplinary responsibility. A declaration has greater value when it does more than state aspirations; it becomes consequential when it identifies clear areas in which institutions will continue to collaborate after the summit ends.
Pakistan’s next major healthcare achievement may come from a laboratory, an operating theatre or an artificial intelligence platform. But an equally important achievement will be creating institutions capable of governing those advances with legal certainty, ethical judgement and public trust.
The question facing modern healthcare is no longer only what medicine can make possible. It is whether our institutions are prepared to manage those possibilities responsibly. HESP 2026 offers a timely place to begin that conversation. Its opportunity should not be missed.
—
Dr Bilal Hussain Assistant Professor of Law at Rashid Latif Khan University (RLKU). This research examines the intersection of law, medicine, Islamic ethics and emerging technology, particularly in the fields of reproductive governance, bioethics and health-technology law. The views expressed are personal.
